Aytu BioPharma (NASDAQ:AYTU) is preparing to release its quarterly earnings on Thursday, 2025-11-13. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect Aytu BioPharma to report an earnings per share (EPS) of $-0.14.

Investors in Aytu BioPharma are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Earnings History Snapshot

Last quarter the company missed EPS by $0.21, which was followed by a 17.93% drop in the share price the next day.

Here's a look at Aytu BioPharma's past performance and the resulting price change:

Quarter

Q4 2025

Q3 2025

Q2 2025

Q1 2025

EPS Estimate

-0.04

-0.17

0.00

-0.34

EPS Actual

-0.25

0.21

-0.28

-0.20

Price Change %

-18.00

92.00

-1.00

-11.00

Performance of Aytu BioPharma Shares

Shares of Aytu BioPharma were trading at $2.1 as of November 11. Over the last 52-week period, shares are up 36.77%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

Analyst Insights on Aytu BioPharma

For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest ...